Pyrr, thanks for reposting this.
Prompted me to do my own (very rudimentary) model based on the Phase I K-M curves, and I got something similar in terms of timing and enrollees. I'm not a stat person, so no p values, but gives me additional confidence that what is being seen is an efficacy advantage in the ballpark of that seen in the Phase I.